[与里芬素,酸和伊特拉科纳一起危及生命的心脏毒性]
Nanna Reiter1,2, Julie Bjerre Tarp3, Hasse Møller-Sørensen4
1Anæstesiologisk Afdeling Z, Københavns Universitetshospital - Bispebjerg og Frederiksberg Hospital.
Ugeskrift for laeger
|March 24, 2025
概括
一个严重的药物相互作用在一个年轻人服用利芬素,酸和伊特拉科纳后引起了危及生命的心脏毒性. 身体外膜氧化 (ECMO) 对他的康复至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 心脏病学 心脏病学
背景情况:
- 药物相互作用可能导致严重的,意想不到的不良事件.
- 利芬素,酸和伊特拉科纳是常见的抗生素和抗真菌药物.
- 心脏毒性是某些药物组合的罕见但严重的副作用.
研究的目的:
- 报告一个危及生命的心脏毒性病例.
- 突出药物相互作用在这种不良事件中的作用.
- 强调ECMO在严重中毒管理中的有用性.
主要方法:
- 一个19岁的男性患者的案例回顾.
- 药物摄入的分析:里芬素,酸和伊特拉科纳.
- 临床管理包括体外膜氧化 (ECMO).
主要成果:
- 患者经历了严重的心脏毒性,尽管低剂量里法匹辛.
- 同时使用伊特拉科纳和酸抑制了里芬素的消除.
- 对于患者的康复和器官功能来说,ECMO的支持至关重要.
结论:
- 与伊特拉科纳和酸同时服用利芬素可能会导致严重的心脏毒性.
- 在临床实践中,对药物相互作用的认识至关重要.
- 在严重的药物中毒中,ECMO可以作为挽救生命的桥梁来恢复.
相关概念视频
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
867
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
867
Heart Failure Drugs: Inotropic Agents
476
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
476
Pulmonary Tuberculosis I
212
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
212
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.1K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
119
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
119
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
741
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
741


